Prof Terrance Chua News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prof terrance chua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prof Terrance Chua Today - Breaking & Trending Today

Bayer, National Heart Center Singapore to develop explorative cardiovascular center

Bayer, National Heart Center Singapore to develop explorative cardiovascular center
By Anh Nguyen December 22, 2020 | 04:43 pm GMT+7
Bayer and National Heart Center Singapore (NHCS) announced they had inked a five-year agreement to develop a “Center of Excellence for Explorative Cardiovascular Studies.”
The center aims to boost patient-centricity in research and development (R&D) and improve treatment outcomes in cardiovascular disease (CVD) management.
Combining NHCS’s vast experience in managing Asian CVD patients and clinical research with Bayer’s expertise in pharmaceutical R&D, the center will generate and integrate high quality patient data into early clinical research that would allow better understanding of the underlying biology of CVDs. Results could potentially lead to future targeted therapies to address unmet medical needs in defined patient populations. Bayer will contribute S$5.4 million ($4 million) towards the setup of the center. ....

Asia Pacific , Philip Larsen , Terrance Chua , National Heart Centre Singapore , Bayer Pharmaceuticals Division , National Heart Center Singapore , Clinical Research , Explorative Cardiovascular , Prof Terrance Chua , Professor Carolyn Lam , Preclinical Research , Bayer Pharmaceuticals , ஆசியா பெஸிஃபிக் , பிலிப் லார்சன் , டெரன்ஸ் சுய , தேசிய இதயம் மையம் சிங்கப்பூர் , பேயர் மருந்துகள் பிரிவு , மருத்துவ ஆராய்ச்சி , ப்ரொஃப் டெரன்ஸ் சுய , ப்ரொஃபெஸர் கரோலின் லாம் , பேயர் மருந்துகள் ,

Bayer and the National Heart Centre Singapore collaborate to set up Center of Excellence

E-Mail
Leveraging on Asian patient data, the 5-year collaboration aims to boost patientcentricity in R&D, leading to improved treatment outcomes in cardiovascular disease (CVD) management.
The Center will generate and integrate high quality patient data into early clinical research to inform future targeted therapies for CVDs.
Bayer will contribute S$5.4million (approx. EUR 3.4 million) towards this
collaboration.
Singapore, December 17, 2020 - Bayer and National Heart Centre Singapore (NHCS) today announced that they have entered into a 5-year collaboration agreement to set up Center of Excellence for Explorative Cardiovascular Studies (hereinafter Center ) with the aim of boosting patient-centricity in research and development (R&D) and improving treatment outcomes in cardiovascular disease (CVD) management. Combining NHCS vast ....

Van Phuoc , Asia Pacific , Jane Yeo , Jean Angus , Philip Larsen , Terrance Chua , National Heart Centre Singapore , Department Of Cardiology , Principal Investigator Of The Center , Bayer Pharmaceuticals Division , Singapore Heart Foundation , Clinical Research , Explorative Cardiovascular , Prof Terrance Chua , Medical Director , Senior Consultant , Professor Carolyn Lam , Principal Investigator , Preclinical Research , Bayer Pharmaceuticals , Med Res Opin , Heart Foundation , National Heart Centre , வேன் புோக் , ஆசியா பெஸிஃபிக் , ஜேன் ஆம் ,